TrialThe Journal of dermatology2022

Efficacy and safety of apremilast and phototherapy versus phototherapy only in psoriasis vulgaris.

Akimichi Morita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.